Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

BenevolentAI begins first-in-human trial of BEN-2293 for atopic dermatitis

Feb. 12, 2021

Morphine itch comes from neurons, not mast cells

Feb. 9, 2021

China's NMPA accepts Kintor's IND for topical AR degrader GT-20029

Feb. 4, 2021

Akari announces development of its second clinical candidate, votucalis

Feb. 3, 2021

Topline data from pivotal DERMIS-1 and -2 studies of ARQ-151 in plaque psoriasis

Feb. 2, 2021

PF-06826647 is safe and significantly improves disease activity in subjects with plaque psoriasis

Jan. 29, 2021

BirchBioMed reports phase II data on FS-2 for keloid scars

Jan. 25, 2021

Molecularly, skin disease shares much with development

Jan. 25, 2021

Target enrollment complete in diabetic foot ulcer study of SkinTE

Jan. 22, 2021

12-Week study shows benvitimod cream is efficacious and safe in plaque psoriasis

Jan. 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...